NEO•benzinga•
Raymond James Maintains Outperform on NeoGenomics, Lowers Price Target to $15
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2022 by benzinga